Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 203 articles: HTML format

Single Articles

February 2026
1. HASIL L, Milks A, Panagakos A, Engel D, et al
   What is the impact of nutrition interventions on incidence of anastomotic leak after colorectal surgery? A systematic review of randomized trials.
   Eur J Surg Oncol. 2026;52:111321.
   PubMed     Abstract available
   
   
   
2. UNE N, Kobayashi S, Kudo M, Sugimoto M, et al
   Response to chemotherapy as a key factor in time to surgical failure following conversion hepatectomy for initially unresectable colorectal liver metastases: A retrospective cohort study.
   Eur J Surg Oncol. 2026;52:111317.
   PubMed     Abstract available
   
   
   
3. JISHU JA, Bruce D, Abu AlSel BT, Othman R, et al
   Minimally invasive approaches for early-stage rectal cancer: A comparative analysis from the TriNetX network.
   Eur J Surg Oncol. 2026;52:111318.
   PubMed     Abstract available
   
   
   January 2026
4. GRANADOS-MATURANO A, Garcia-Nalda A, Pallisera-Lloveras A, Pujol-Caballe G, et al
   Colorectal cancer surgery in elderly and frail patients: Should we leave someone behind?
   Eur J Surg Oncol. 2026;52:111406.
   PubMed     Abstract available
   
   
   
5. GLAZEMAKERS ST, Ketelaers SHJ, Cornelisse HB, de Wit F, et al
   Extended thromboprophylaxis in enhanced recovery after surgery for colorectal cancer: a multicentre retrospective cohort study.
   Eur J Surg Oncol. 2026;52:111378.
   PubMed     Abstract available
   
   
   
6. ABERLE MR, Ligthart MAP, West MA, Rensen SS, et al
   Gain of visceral adipose tissue rather than low skeletal muscle mass is associated with overall survival in patients with colorectal liver metastases; results from the NewEPOC study.
   Eur J Surg Oncol. 2026;52:111179.
   PubMed     Abstract available
   
   
   
7. BROWN KGM, Ng KS, Solomon MJ, Vu J, et al
   Preoperative predictors of priority outcomes of pelvic exenteration for locally recurrent rectal cancer: Results of the mixed-methods EviSurg study.
   Eur J Surg Oncol. 2026;52:111183.
   PubMed     Abstract available
   
   
   
8. CICERONE O, Corallo S, De Silvestri A, Serra F, et al
   Anti-EGFR plus chemotherapy vs. chemotherapy alone in RAS wild-type colorectal liver metastases: A meta-analysis of survival outcomes in resectable and unresectable settings.
   Eur J Surg Oncol. 2026;52:111155.
   PubMed     Abstract available
   
   
   December 2025
9. STICCA G, Soucisse M, Abou-Khalil M, Gervais MK, et al
   Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastases.
   Eur J Surg Oncol. 2025;51:110534.
   PubMed     Abstract available
   
   
   
10. CHATZIPANAGIOTOU OP, Kawashima J, Baldo A, Ruzzenente A, et al
    Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden score.
    Eur J Surg Oncol. 2025;51:110527.
    PubMed     Abstract available
    
    
    
11. VAN DEN HEUVEL TBM, van Erning FN, Hemmer PHJ, Madsen EVE, et al
    Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry.
    Eur J Surg Oncol. 2025;51:110501.
    PubMed     Abstract available
    
    
    
12. ALTINSOY E, Ozcan VC, Zeynalov H, Cebeci? E, et al
    An onco-vascular surgical approach: Internal iliac artery transposition for external iliac artery repair during cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:110503.
    PubMed     Abstract available
    
    
    
13. DE GRAAFF MR, Kok NFM, Grunhagen DJ, Nielen M, et al
    Influence of socioeconomic position on surgical outcomes after resection of colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:110459.
    PubMed     Abstract available
    
    
    
14. YE Q, Liu M, Xu M, Cui M, et al
    Correlation of supportive proton pump inhibitor use during surgery with outcomes in patients with stage I-III colorectal cancer: A propensity score matching study.
    Eur J Surg Oncol. 2025;51:110543.
    PubMed     Abstract available
    
    
    
15. PAU S, Eglinton T, Wang A, Fischer J, et al
    Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors.
    Eur J Surg Oncol. 2025;51:110537.
    PubMed     Abstract available
    
    
    November 2025
16. EMILE SH, Horesh N, Wignakumar A, Boutros M, et al
    Advanced T stage and nodal disease are independently associated with worse cancer-specific survival in stage IV colorectal cancer: A SEER-based survival analysis.
    Eur J Surg Oncol. 2025;52:111315.
    PubMed     Abstract available
    
    
    
17. BIRCH RJ, Taylor JC, Downing A, Burr NE, et al
    Understanding the relationship between surgical specialisation and outcomes following emergency surgery for colorectal cancer - a retrospective population-based study in the English NHS.
    Eur J Surg Oncol. 2025;52:111181.
    PubMed     Abstract available
    
    
    
18. XIAO C, Zhang W, Qiu M, He D, et al
    A transformer-based pathomics model using endoscopic biopsy WSIs for predicting pathological complete response to preoperative immunotherapy in colorectal cancer.
    Eur J Surg Oncol. 2025;52:111182.
    PubMed     Abstract available
    
    
    
19. LAU J, Ng A, Koh WL, Lee KY, et al
    The impact of colorectal cancer on quality of life of younger adults: A qualitative longitudinal approach.
    Eur J Surg Oncol. 2025;52:111169.
    PubMed     Abstract available
    
    
    
20. YI T, Liang Y, Li X, Lin Z, et al
    Machine learning analysis for recurrence prediction of colorectal cancer liver metastases.
    Eur J Surg Oncol. 2025;52:111168.
    PubMed     Abstract available
    
    
    
21. O'NEILL MA, Harrold EC, Gillham C, Ryan C, et al
    Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case series.
    Eur J Surg Oncol. 2025;52:111166.
    PubMed     Abstract available
    
    
    
22. RIJSEMUS CJV, Kok NFM, Lahaye MJ
    Reply to Zhang, 'Comment on: Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index'.
    Eur J Surg Oncol. 2025;51:109652.
    PubMed    
    
    
    
23. DE GRAAFF MR, Klaase JM, den Dulk M, Grunhagen DJ, et al
    Selection for local treatment and outcomes of surgical resection in patients with synchronous colorectal liver metastases: A nationwide population-based study.
    Eur J Surg Oncol. 2025;51:110411.
    PubMed     Abstract available
    
    
    
24. DE LA MOTTE L, Tapper J, Arver S, Holm T, et al
    Long-term impact of preoperative radiotherapy for rectal cancer on testicular function.
    Eur J Surg Oncol. 2025;51:110458.
    PubMed     Abstract available
    
    
    
25. MCKIGNEY N, van Rees JM, Nordkamp S, Waldenstedt S, et al
    Cross-cultural adaptation of the locally recurrent rectal cancer - Quality of life questionnaire.
    Eur J Surg Oncol. 2025;51:110363.
    PubMed     Abstract available
    
    
    
26. ENBLAD M, Ghanipour L, Palmer G, Valdimarsson V, et al
    Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases - a Swedish population-based study.
    Eur J Surg Oncol. 2025;51:110429.
    PubMed     Abstract available
    
    
    
27. DENG Y, Li Y, Zhang R, Wang Z, et al
    Pre-treatment S-index as a promising prognostic indicator of treatment response and survival in patients with synchronous colorectal liver metastases: A retrospective multi-center study.
    Eur J Surg Oncol. 2025;51:110371.
    PubMed     Abstract available
    
    
    
28. TEN BRINK R, Schram R, Kats-Ugurlu G, Kwee T, et al
    Feasibility of optical stereotactic navigation for rectosigmoid cancer with deep learning-supported 3D modelling.
    Eur J Surg Oncol. 2025;51:110397.
    PubMed     Abstract available
    
    
    
29. MORGAN M, Ben C, Peter M, Fiachra C, et al
    Local excision versus total mesorectal excision following neoadjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110398.
    PubMed     Abstract available
    
    
    
30. WILLIAMS A, O'Neill C, Hutchings H, Quyn A, et al
    Exploring decision making for treatment in LARC and LRRC: A qualitative study.
    Eur J Surg Oncol. 2025;51:110372.
    PubMed     Abstract available
    
    
    October 2025
31. HANAOKA M, Kataoka K, Mizusawa J, Ouchi A, et al
    Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2).
    Eur J Surg Oncol. 2025;52:110545.
    PubMed     Abstract available
    
    
    
32. BEN HMIDO S, Abder Rahim H, Ingwersen EW, Burchell G, et al
    Transparency in Externally Validated Models: A systematic review of machine learning vs. logistic regression for predicting colorectal anastomotic leakage.
    Eur J Surg Oncol. 2025;51:110367.
    PubMed     Abstract available
    
    
    
33. GOBARDHAN PD, Veen EJ, Rijken AM, Ayez N, et al
    Video-assisted total transthoracic liver resection for colorectal liver metastasis, safety and feasibility.
    Eur J Surg Oncol. 2025;51:110389.
    PubMed     Abstract available
    
    
    
34. KANG B, Qiao Y, Song J, Zhang Z, et al
    Interpretable machine learning model for predicting perioperative Clavien-Dindo III/IV complications of rectal cancer anterior resection after neoadjuvant therapy: a real-world study.
    Eur J Surg Oncol. 2025;51:110365.
    PubMed     Abstract available
    
    
    
35. NAESSENS C, Evin C, Le-Malicot K, Lemanski C, et al
    Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE.
    Eur J Surg Oncol. 2025;51:110346.
    PubMed     Abstract available
    
    
    
36. GOULD LE, Pring ET, Wallace A, Hodges N, et al
    Clinical determinants of outcome following pelvic exenteration for locally advanced or locally recurrent rectal cancer.
    Eur J Surg Oncol. 2025;51:110347.
    PubMed     Abstract available
    
    
    
37. WANG Z, Liu Q
    A retrospective analysis of 44 diminutive rectal neuroendocrine neoplasms that were not suitable for local treatment.
    Eur J Surg Oncol. 2025;51:110348.
    PubMed     Abstract available
    
    
    
38. EMILE SH, Horesh N, Garoufalia Z, Wignakumar A, et al
    Association between the type of pre-existing adenoma and response of rectal cancer to neoadjuvant therapy.
    Eur J Surg Oncol. 2025;51:110319.
    PubMed     Abstract available
    
    
    
39. WILLIAMS T, Hayler R, Garrett C, Barat S, et al
    Impact of diaphragmatic intervention in cytoreductive surgery with heated intraperitoneal chemotherapy for colorectal carcinoma.
    Eur J Surg Oncol. 2025;51:110306.
    PubMed     Abstract available
    
    
    
40. GU YC, Yang M, Geng Y, Zhang B, et al
    Tumor-Boundary Response Index (TBRI)- A promising indicator for predicting outcomes in colorectal liver metastases receiving neoadjuvant therapy: Insights from a single-center retrospective study.
    Eur J Surg Oncol. 2025;51:110291.
    PubMed     Abstract available
    
    
    September 2025
41. ZHOU Y, Zhao J, Tan Y, Zou F, et al
    CT-based radiomics deep learning signatures for noninvasive prediction of early recurrence after radical surgery in locally advanced colorectal cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:110482.
    PubMed     Abstract available
    
    
    
42. HOANG VM, Turner B, Ho R, Tucker J, et al
    The impact of colorectal cancer diagnosis and treatment on quality of life is increased in young patients.
    Eur J Surg Oncol. 2025;51:110483.
    PubMed     Abstract available
    
    
    
43. XIAO J, Gu C, Wu Q, Yang X, et al
    Feasibility of ambulatory colectomy in the tertiary hospital with surveillance in the community hospital: A propensity score-matched study.
    Eur J Surg Oncol. 2025;51:110077.
    PubMed     Abstract available
    
    
    
44. CREEMERS DMJ, Mens DM, Nordkamp S, Piqeur F, et al
    Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort.
    Eur J Surg Oncol. 2025;51:110261.
    PubMed     Abstract available
    
    
    
45. NG JC, Sassun R, Sileo A, Violante T, et al
    Real-world clinical outcomes of total neoadjuvant therapy followed by total mesorectal excision for locally advanced rectal cancer at a high-volume institution.
    Eur J Surg Oncol. 2025;51:110181.
    PubMed     Abstract available
    
    
    
46. HAQ MU, Pritchard DM, Hughes DM, Javed MA, et al
    Long-term outcomes of patients treated with contact X-ray brachytherapy and external beam (chemo)radiotherapy following local excision of rectal adenocarcinoma.
    Eur J Surg Oncol. 2025;51:110216.
    PubMed     Abstract available
    
    
    
47. NOIRET B, Koo CH, Bacci M, Lamichhane NB, et al
    Clinical contexts for Shared Decision-Making in rectal cancer: Organ preservation, sphincter-sparing surgery and tailored stoma policy.
    Eur J Surg Oncol. 2025;51:110196.
    PubMed     Abstract available
    
    
    
48. MENS DM, Coebergh van den Braak RRJ, Hilling DE, Meyer V, et al
    Nationwide analysis on the role of neoadjuvant radiotherapy and watch and wait in rectal cancer.
    Eur J Surg Oncol. 2025;51:110179.
    PubMed     Abstract available
    
    
    
49. MENS DM, van Rees JM, Husson O, Crolla RMPH, et al
    Impact of minimal invasive surgery techniques on long-term health-related quality of life in rectal cancer: a Dutch cohort study.
    Eur J Surg Oncol. 2025;51:110180.
    PubMed     Abstract available
    
    
    
50. KEFLEYESUS A, Bakrin N, Kepenekian V, Gerbaud-Coulas C, et al
    Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility.
    Eur J Surg Oncol. 2025;51:110150.
    PubMed     Abstract available
    
    
    August 2025
51. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Rethinking TNM: Tumor deposit-based prognostic models may improve N-staging in colorectal cancer.
    Eur J Surg Oncol. 2025;51:110420.
    PubMed     Abstract available
    
    
    
52. SABAJO CR, Michels CTJ, van der Hout A, van den Heuvel B, et al
    The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis.
    Eur J Surg Oncol. 2025;51:110375.
    PubMed     Abstract available
    
    
    
53. CATARCI M, Guadagni S, Scatizzi M, De Luca R, et al
    Enhanced recovery and survival after elective surgery for colorectal cancer - propensity score weighting analysis of 2,865 prospective patients.
    Eur J Surg Oncol. 2025;51:110379.
    PubMed     Abstract available
    
    
    
54. GOOIJER SA, Gazendam ASM, Torensma B, Tuynman JB, et al
    Metastasectomy versus stereotactic body radiotherapy for patients with oligometastatic colorectal lung metastases: a systematic review.
    Eur J Surg Oncol. 2025;51:110056.
    PubMed     Abstract available
    
    
    
55. KAZI M, Ajith A, Bhatt A
    The Mitomycin versus Oxaliplatin debate on HIPEC in colorectal cancers - An updated systematic review and Meta-analysis.
    Eur J Surg Oncol. 2025;51:110080.
    PubMed     Abstract available
    
    
    
56. HORESH N, Emile SH, Garoufalia Z, Gefen R, et al
    Network meta-analysis of RTCs for efficacy of neoadjuvant treatment in rectal cancer.
    Eur J Surg Oncol. 2025;51:110019.
    PubMed     Abstract available
    
    
    
57. TSAI ML, Hung JS, Huang J, Lin BR, et al
    Factors associated with leakage after reversal of protective stoma in patients with locally advanced rectal cancer following curative resection and anastomosis.
    Eur J Surg Oncol. 2025;51:108698.
    PubMed     Abstract available
    
    
    
58. SU YM, Jin KM, Wang HW, Wang YY, et al
    Survival prediction of colorectal liver metastases underwent surgical resection after neoadjuvant chemotherapy: Tumor response combined with the genetic and morphological evaluation score.
    Eur J Surg Oncol. 2025;51:108777.
    PubMed     Abstract available
    
    
    July 2025
59. MA Y
    Comment on "A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis".
    Eur J Surg Oncol. 2025;51:110315.
    PubMed    
    
    
    
60. ZOU M, Yang Z, Feng J, Yang Z, et al
    Comment on: "Muscle-specific strength predicts postoperative complications and survival in patients undergoing curative colectomy for colorectal cancer".
    Eur J Surg Oncol. 2025;51:110321.
    PubMed    
    
    
    
61. ABUDUAINI N, Wang X, Fingerhut A, Zheng M, et al
    Short-term outcomes of transanal endoscopic intersphincteric resection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A single-center retrospective cohort study.
    Eur J Surg Oncol. 2025;51:109984.
    PubMed     Abstract available
    
    
    
62. POWELL SG, Wyatt JNR, Rao C, Dhadda A, et al
    Contact X-ray brachytherapy in rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109976.
    PubMed     Abstract available
    
    
    
63. WETTERHOLM E, Ronnow CF, Thorlacius H
    Risk of recurrence following transanal endoscopic microsurgery without neoadjuvant or adjuvant treatment in T2 rectal cancer.
    Eur J Surg Oncol. 2025;51:109974.
    PubMed     Abstract available
    
    
    
64. JEHAES C, Panis Y, Fernandez L, Lelong B, et al
    Risk of distant metastasis after local excision for near-complete response versus salvage surgery for local regrowth in rectal cancer: Results from an international registry.
    Eur J Surg Oncol. 2025;51:109761.
    PubMed     Abstract available
    
    
    
65. BANKEN E, Creemers DMJ, Kerckhove FECV, Ketelaers SHJ, et al
    Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survival.
    Eur J Surg Oncol. 2025;51:109758.
    PubMed     Abstract available
    
    
    
66. BHIMANI N, Dieng M, Kelly PJ, Hugh TJ, et al
    Colorectal liver metastasis resection results in excellent long-term quality of life and low symptom burden.
    Eur J Surg Oncol. 2025;51:109751.
    PubMed     Abstract available
    
    
    
67. FOPPA C, Maroli A, Carvello M, La Raja C, et al
    Long-term functional outcomes after Transanal Transection and Single-Stapled (TTSS) anastomosis for rectal cancer measured by electronic Patients Reported Outcome Measures (ePROMs).
    Eur J Surg Oncol. 2025;51:109759.
    PubMed     Abstract available
    
    
    
68. BOLDRINI L, Charles-Davies D, Romano A, Mancino M, et al
    Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review.
    Eur J Surg Oncol. 2025;51:109463.
    PubMed     Abstract available
    
    
    June 2025
69. LIU W, He F, Chen D, Zhang X, et al
    Impact of previous abdominal surgery on minimally invasive radical resection of colorectal cancer: A meta-analysis.
    Eur J Surg Oncol. 2025;51:110259.
    PubMed     Abstract available
    
    
    
70. GOEDEGEBUURE EP, Arico FM, Lahaye MJ, Maas M, et al
    Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.
    Eur J Surg Oncol. 2025;51:109700.
    PubMed     Abstract available
    
    
    
71. SU J, Liu Z, Li H, Kang L, et al
    Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer.
    Eur J Surg Oncol. 2025;51:109717.
    PubMed     Abstract available
    
    
    
72. BOND MJG, Verhoef C, Kazemier G, Kok NFM, et al
    Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.
    Eur J Surg Oncol. 2025;51:109681.
    PubMed     Abstract available
    
    
    
73. AHMADINEJAD M, Parvizi A, Sheikhi S, Eghbal F, et al
    Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis.
    Eur J Surg Oncol. 2025;51:109702.
    PubMed     Abstract available
    
    
    
74. MOOLENAAR LR, van Geffen EGM, Hazen SJA, Sluckin TC, et al
    Salvageable locoregional recurrence and stoma rate after local excision of pT1-2 rectal cancer - A nationwide cross-sectional cohort study.
    Eur J Surg Oncol. 2025;51:109623.
    PubMed     Abstract available
    
    
    
75. MONTALTI R, Pepe F, Cassese G, Russo G, et al
    Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study.
    Eur J Surg Oncol. 2025;51:109706.
    PubMed     Abstract available
    
    
    May 2025
76. WOERNER J, Nam Y, Jung SH, Shivakumar M, et al
    Leveraging automated machine learning to predict colon cancer prognosis from clinical features and risk groups: a retrospective cohort study.
    Eur J Surg Oncol. 2025;51:110194.
    PubMed     Abstract available
    
    
    
77. ZHANG Y, Li J, Guan X, Wang S, et al
    Impact of lymph node metastasis on prognosis in colorectal cancer patients with liver metastasis and staging systems Refinement: An international multicenter retrospective cohort study.
    Eur J Surg Oncol. 2025;51:110124.
    PubMed     Abstract available
    
    
    
78. AWAIS AM, Awais AR
    LTE: Enhancing colorectal cancer patient selection for cytoreductive surgery: The role of artificial intelligence and integration of pathological peritoneal cancer index in improving clinical outcomes.
    Eur J Surg Oncol. 2025;51:110122.
    PubMed    
    
    
    
79. LAKHA AS, Sud V, Alemour Y, Perera NJ, et al
    Simultaneous versus delayed resection of synchronous colorectal liver metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109732.
    PubMed     Abstract available
    
    
    
80. VAN DEN BERG K, Banken E, van Rees JM, Coolen LM, et al
    Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres.
    Eur J Surg Oncol. 2025;51:109699.
    PubMed     Abstract available
    
    
    
81. MAEKAWA A, Omiya K, Oba A, Inoue Y, et al
    Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:109635.
    PubMed     Abstract available
    
    
    
82. YANG W, Li C, Luo J, Feng Y, et al
    Transcatheter rectal arterial chemoembolization with oxaliplatin and concurrent chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective comparative study.
    Eur J Surg Oncol. 2025;51:109582.
    PubMed     Abstract available
    
    
    April 2025
83. ASSI H, Valdimarsson V, Angenete E, Buchwald P, et al
    Survival after urological resections in colorectal cancer - a Swedish nationwide study.
    Eur J Surg Oncol. 2025;51:110078.
    PubMed     Abstract available
    
    
    
84. JESSEN SB, Vogelsang RP, Dolin TG, Jorgensen J, et al
    Surgery-related change in cancer cell adhesion associates with recurrence in patients undergoing colorectal cancer surgery.
    Eur J Surg Oncol. 2025;51:110055.
    PubMed     Abstract available
    
    
    
85. ZHAI WB, Li ZZ, He CH, Xi WT, et al
    Muscle-specific strength predicts postoperative complications and survival in patients undergoing curative colectomy for colorectal cancer.
    Eur J Surg Oncol. 2025;51:110020.
    PubMed     Abstract available
    
    
    March 2025
86. VAN GANSEWINKEL EHE, van den Heuvel TBM, van Erning FN, De Hingh IHJT, et al
    Combined peritoneal and liver metastases in colorectal cancer: A Dutch nationwide population-based analysis of incidence, treatment and survival.
    Eur J Surg Oncol. 2025;51:109999.
    PubMed     Abstract available
    
    
    
87. PAWAR A, Kepenekian V, Omar A, Bel N, et al
    Influence of lung metastases on outcomes of curative management of peritoneal metastases from colorectal cancer.
    Eur J Surg Oncol. 2025;51:109650.
    PubMed     Abstract available
    
    
    
88. LIN Q, Chen C, Li K, Cao W, et al
    A deep-learning model to predict the completeness of cytoreductive surgery in colorectal cancer with peritoneal metastasis?.
    Eur J Surg Oncol. 2025;51:109760.
    PubMed     Abstract available
    
    
    
89. ZHANG X, Chen J, He F, Du W, et al
    Comparing efficacy and safety of transanal vs. laparoscopic total mesorectal excision for middle and low rectal cancer: Updated meta-analysis.
    Eur J Surg Oncol. 2025;51:109559.
    PubMed     Abstract available
    
    
    
90. TWEED TTT, Tummers S, Boerma EG, Bouvy ND, et al
    Minimal invasive surgery protects against severe postoperative complications regardless of body composition in patients undergoing colorectal surgery.
    Eur J Surg Oncol. 2025;51:109561.
    PubMed     Abstract available
    
    
    
91. QIU W, Hu G, Mei S, Li Y, et al
    Indocyanine green highlights the lymphatic drainage pathways, enhancing the effectiveness of radical surgery for mid-low rectal cancer: A non-randomized controlled prospective study.
    Eur J Surg Oncol. 2025;51:109520.
    PubMed     Abstract available
    
    
    
92. MATEUSIAK L, Hakuno S, de Jonge-Muller ESM, Floru S, et al
    Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery.
    Eur J Surg Oncol. 2025;51:109537.
    PubMed     Abstract available
    
    
    
93. AMMIRABILE A, Cavinato L, Ferro CAP, Fiz F, et al
    CT-radiomics and pathological tumor response to systemic therapy: A predictive analysis for colorectal liver metastases. Development and internal validation of a clinical-radiomic model.
    Eur J Surg Oncol. 2025;51:109557.
    PubMed     Abstract available
    
    
    February 2025
94. CARRION-ALVAREZ L, Primavesi F, Soreide K, Sochorova D, et al
    Liver metastases from colorectal cancer: A joint ESSO-EAHPBA-UEMS core curriculum collaboration.
    Eur J Surg Oncol. 2025;51:109728.
    PubMed     Abstract available
    
    
    
95. TIWARI A, Lee SL, MacCabe T, Woyton M, et al
    Intraoperative electron radiotherapy (IOERT) in colorectal cancer: Updated systematic review of techniques, oncological outcomes and complications.
    Eur J Surg Oncol. 2025;51:109724.
    PubMed     Abstract available
    
    
    
96. GHABRA S, Chang D, Sugarbaker PH
    Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:109720.
    PubMed     Abstract available
    
    
    
97. ALTAF A, Kawashima J, Khalil M, Stecko H, et al
    Identification of a gene signature and prediction of overall survival of patients with stage IV colorectal cancer using a novel machine learning approach.
    Eur J Surg Oncol. 2025;51:109718.
    PubMed     Abstract available
    
    
    
98. TANG J, Liao L, Xiao B, Sui Q, et al
    Efficacy and safety of subtotal pelvic peritonectomy for colorectal cancer patients with peritoneal metastasis confined to the pelvic cavity.
    Eur J Surg Oncol. 2025;51:109703.
    PubMed     Abstract available
    
    
    
99. GIRARDI L, Mallick R, Wang TF, Carrier M, et al
    Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
    Eur J Surg Oncol. 2025;51:109701.
    PubMed     Abstract available
    
    
    
100. GROEN LC, Timmers TG, Daams FD, Doodeman HJ, et al
     Fit4Surgery app: Home-based prehabilitation app for older patients undergoing elective colorectal cancer surgery.
     Eur J Surg Oncol. 2025;51:109691.
     PubMed     Abstract available
     
     
     
101. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
     Reply to: Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
     Eur J Surg Oncol. 2025 Feb 6:109655. doi: 10.1016/j.ejso.2025.109655.
     PubMed    
     
     
     
102. CHEN J, Liu X
     Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomized controlled trials".
     Eur J Surg Oncol. 2025;51:109656.
     PubMed    
     
     
     
103. YANAGISAWA T, Tatematsu N, Asano S, Horiuchi M, et al
     Perioperative decline in isometric knee extension force is a predictor of unplanned readmission within 1 year in patients with colorectal cancer.
     Eur J Surg Oncol. 2025;51:109673.
     PubMed     Abstract available
     
     
     
104. WANG X
     Revisiting colonic obstruction criteria and optimal timing for SEMS placement in colon cancer.
     Eur J Surg Oncol. 2025;51:109631.
     PubMed    
     
     
     
105. BAE SU, Lee JL, Yang CS, Park EJ, et al
     Survival benefit of adjuvant chemotherapy in high-risk patients with colon cancer regardless of microsatellite instability.
     Eur J Surg Oncol. 2025;51:109674.
     PubMed     Abstract available
     
     
     
106. VEEN T, Kanani A, Zaharia C, Lea D, et al
     Treatment-sequencing before and after index hepatectomy with either synchronous or metachronous colorectal liver metastasis: Comparison of recurrence risk, repeat hepatectomy and overall survival in a population-derived cohort.
     Eur J Surg Oncol. 2025;51:109540.
     PubMed     Abstract available
     
     
     
107. NG WH, Machado C, Rooney A, Jones R, et al
     Ablative techniques in colorectal liver metastases: A systematic review, descriptive summary of practice, and recommendations for optimal data reporting.
     Eur J Surg Oncol. 2025;51:109487.
     PubMed     Abstract available
     
     
     
108. BRIERE R, Simard AJ, Rouleau-Fournier F, Letarte F, et al
     Perioperative management and survival outcomes following cytoreductive surgery in patients with peritoneal metastases from rectal cancer: A scoping review.
     Eur J Surg Oncol. 2025;51:109498.
     PubMed     Abstract available
     
     
     January 2025
109. LIU X, Zhang CJ
     Reply to: Comment on "Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index".
     Eur J Surg Oncol. 2025 Jan 30:109653. doi: 10.1016/j.ejso.2025.109653.
     PubMed    
     
     
     
110. MEHTA R, Sah R, Kumar S
     Comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
     Eur J Surg Oncol. 2025 Jan 28:109637. doi: 10.1016/j.ejso.2025.109637.
     PubMed    
     
     
     
111. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
     Reply to comment on "Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials".
     Eur J Surg Oncol. 2025 Jan 28:109636. doi: 10.1016/j.ejso.2025.109636.
     PubMed    
     
     
     
112. RIJSEMUS CJV, Kok NFM, Aalbers AGJ, Grotenhuis BA, et al
     Can surgeons predict the extent of abdominal surgery based on MRI findings in CRS-HIPEC candidates with colorectal cancer?
     Eur J Surg Oncol. 2025;51:109583.
     PubMed     Abstract available
     
     
     
113. JERI-MCFARLANE S, Garcia-Granero A, Martinez-Ortega MA, Amengual-Antich I, et al
     Tailored-surgery for locally advanced colon cancer based on 3D mathematical reconstruction surgical planner: Observational comparative non-randomized study.
     Eur J Surg Oncol. 2025;51:109584.
     PubMed     Abstract available
     
     
     
114. RAUNKILDE L, Andersen RF, Thomsen CB, Hansen TF, et al
     A prospective study of methylated ctDNA in patients undergoing treatment for liver metastases from colorectal cancer.
     Eur J Surg Oncol. 2025;51:109586.
     PubMed     Abstract available
     
     
     
115. KEARNS EC, Moynihan A, Khan MF, Lawler L, et al
     Comparison and impact of preoperative 3D virtual vascular modelling with intraoperative indocyanine green perfusion angiography for personalized proximal colon cancer surgery.
     Eur J Surg Oncol. 2025;51:109581.
     PubMed     Abstract available
     
     
     
116. DE'ANGELIS N, Schena CA, Azzolina D, Carra MC, et al
     Histopathological outcomes of transanal, robotic, open, and laparoscopic surgery for rectal cancer resection. A Bayesian network meta-analysis of randomized controlled trials.
     Eur J Surg Oncol. 2025;51:109481.
     PubMed     Abstract available
     
     
     
117. SOURROUILLE I, Pastier C, Gelli M, Benhaim L, et al
     Results of complete cytoreductive strategy in patients with peritoneal metastases of colorectal origin with or without extraperitoneal metastases: A bicentric analysis.
     Eur J Surg Oncol. 2025;51:108788.
     PubMed     Abstract available
     
     
     
118. GALANOS LJK, Rijken A, Elferink MAG, Boerma D, et al
     Differences in patient- and tumor characteristics, treatment and survival between patients with screen-detected versus clinically detected colorectal peritoneal metastases.
     Eur J Surg Oncol. 2025;51:108789.
     PubMed     Abstract available
     
     
     December 2024
119. VAN DEN BERG K, van Hellemond IEG, Willems JMWE, Burger JWA, et al
     Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis.
     Eur J Surg Oncol. 2024;51:109560.
     PubMed     Abstract available
     
     
     
120. LOCKHORST EW, Boeding JRE, Wullaert L, Coebergh van den Braak RRJ, et al
     Long-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer.
     Eur J Surg Oncol. 2024;51:109521.
     PubMed     Abstract available
     
     
     
121. BOLMSTRAND B, Nilsson PJ, Eloranta S, Martling A, et al
     Survival after surgery beyond total mesorectal excision for primary locally advanced rectal cancer, a population-based study.
     Eur J Surg Oncol. 2024;50:108673.
     PubMed     Abstract available
     
     
     
122. MCKIGNEY N, Downing A, Velikova G, Brown JM, et al
     Registry-based study comparing health-related quality of life between patients with primary rectal cancer and locally recurrent rectal cancer.
     Eur J Surg Oncol. 2024;50:108736.
     PubMed     Abstract available
     
     
     
123. WANG Y, Pan Z, Li S, Cai H, et al
     Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning.
     Eur J Surg Oncol. 2024;50:108738.
     PubMed     Abstract available
     
     
     
124. HUANG F, Xiao T, Shen G, Zhou S, et al
     Lateral lymph node metastasis without mesenteric lymph node involvement in middle-low rectal cancer: Results of a multicentre lateral node collaborative group study in China.
     Eur J Surg Oncol. 2024;50:108737.
     PubMed     Abstract available
     
     
     
125. SU Y, Li Y, Yang W, Luo X, et al
     Optimized machine learning model for predicting unplanned reoperation after rectal cancer anterior resection.
     Eur J Surg Oncol. 2024;50:108703.
     PubMed     Abstract available
     
     
     
126. GONELLA F, Massucco P, Perotti S, Gianolio S, et al
     Prehab, ERAS, Rehab: A patient care continuum around colo-rectal surgery: Prehabilitation combined with ERAS and rehabilitation to reduce morbidity and hospital stay.
     Eur J Surg Oncol. 2024;50:108688.
     PubMed     Abstract available
     
     
     
127. RIVERA D, Prades J, Borras JM, Aliste L, et al
     Multidisciplinary team meetings and their impact on survival in rectal cancer. Population-based analysis in Catalonia (Spain).
     Eur J Surg Oncol. 2024;50:108675.
     PubMed     Abstract available
     
     
     
128. GARFINKLE R, Bews KA, Perry WRG, Behm KT, et al
     Postoperative bowel dysfunction in patients with rectal cancer - Does a minimally invasive surgical approach improve outcomes?
     Eur J Surg Oncol. 2024;50:108661.
     PubMed     Abstract available
     
     
     
129. VAN ERNING FN, van den Heuvel TBM, Sijtsma FPC, Boerma D, et al
     An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.
     Eur J Surg Oncol. 2024;50:108568.
     PubMed     Abstract available
     
     
     
130. KOLBINGER FR, Bodenstedt S, Carstens M, Leger S, et al
     Artificial Intelligence for context-aware surgical guidance in complex robot-assisted oncological procedures: An exploratory feasibility study.
     Eur J Surg Oncol. 2024;50:106996.
     PubMed     Abstract available
     
     
     November 2024
131. WONG CS, Zaman S, Siddiraju K, Sellvaraj A, et al
     Effects of enteral immunonutrition in laparoscopic versus open resections in colorectal cancer surgery: A meta-analysis of randomised controlled trials.
     Eur J Surg Oncol. 2024;51:109488.
     PubMed     Abstract available
     
     
     
132. PENNINGS AJ, Kimman ML, Renehan AG, Perez RO, et al
     A patient reported outcome measure for rectal cancer patients eligible for organ preservation: Development and validation of a Watch-and-Wait module for the Assessment of Burden of disease in ColoRectal Cancer (ABCRC) tool.
     Eur J Surg Oncol. 2024;51:109501.
     PubMed     Abstract available
     
     
     
133. DUAN M, Liu Z, Qiao Y, Huang P, et al
     Clinical significance of positive resection margin for patients with rectal neuroendocrine tumors within 20 mm following initial endoscopic resection: A multi-center study.
     Eur J Surg Oncol. 2024;50:108651.
     PubMed     Abstract available
     
     
     
134. MEILLAT H, Weets V, Saadoun JE, Tyran M, et al
     Improving the local excision strategy for rectal cancer after chemoradiotherapy: Surgical and oncological results.
     Eur J Surg Oncol. 2024;50:108639.
     PubMed     Abstract available
     
     
     
135. RUSSOLILLO N, Zingaretti CC, Langella S, Fontana AP, et al
     GAME-SCORE predicts pathological and radiological response to chemotherapy in patients with colorectal liver metastases.
     Eur J Surg Oncol. 2024;50:108529.
     PubMed     Abstract available
     
     
     
136. KIM S, Huh JW, Lee WY, Yun SH, et al
     Risk factors and treatment strategies for local recurrence of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
     Eur J Surg Oncol. 2024;50:108641.
     PubMed     Abstract available
     
     
     
137. EMILE SH, Garoufalia Z, Dourado J, Salama E, et al
     Predictors and outcomes of delays between diagnosis and definitive surgery for rectal cancer.
     Eur J Surg Oncol. 2024;50:108618.
     PubMed     Abstract available
     
     
     
138. MAKKER PGS, Koh CE, Solomon M, El-Hayek J, et al
     The influence of postoperative morbidity on long-term quality of life outcomes following pelvic exenteration.
     Eur J Surg Oncol. 2024;50:108640.
     PubMed     Abstract available
     
     
     October 2024
139. KANG JH, Kim EM, Kim MJ, Oh BY, et al
     Comparative analysis of the oncologic outcomes and risk factors for open conversion in laparoscopic surgery for non-metastatic colorectal cancer: A retrospective multicenter study.
     Eur J Surg Oncol. 2024;51:109357.
     PubMed     Abstract available
     
     
     
140. NALLY DM, Kearns EC, Dalli J, Moynagh N, et al
     Patient public perspectives on digital colorectal cancer surgery (DALLAS).
     Eur J Surg Oncol. 2024 Oct 20:108705. doi: 10.1016/j.ejso.2024.108705.
     PubMed     Abstract available
     
     
     
141. KAVASI SB, Iov DE, Rancz A, Zolcsak A, et al
     End-to-end anastomosis provides similar quality-of-life, compared with other reconstructive techniques six months following total mesorectal excision: Systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108599.
     PubMed     Abstract available
     
     
     
142. HUGEN N, Voorham QJM, Beets GL, Loughrey MB, et al
     The mode of circumferential margin involvement in rectal cancer determines its impact on outcomes: A population-based study.
     Eur J Surg Oncol. 2024;50:108598.
     PubMed     Abstract available
     
     
     
143. JAQUET R, Challine A, Tzedakis S, de Ponthaud C, et al
     Impact of the thresholds of surgical volume on mortality in oncological digestive surgery: A French National Cohort.
     Eur J Surg Oncol. 2024;50:108581.
     PubMed     Abstract available
     
     
     
144. ISHIZUKA M, Shibuya N, Hachiya H, Nishi Y, et al
     Robotic surgery is associated with a decreased risk of circumferential resection margin positivity compared with conventional laparoscopic surgery in patients with rectal cancer undergoing mesorectal excision: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108538.
     PubMed     Abstract available
     
     
     
145. YANG X, Bi X
     Reply to "A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein".
     Eur J Surg Oncol. 2024;50:108728.
     PubMed    
     
     
     September 2024
146. CHONG-JIE Z
     Comment on "A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein".
     Eur J Surg Oncol. 2024;50:108729.
     PubMed    
     
     
     
147. FRANSSEN R, Voorn M, Jetten E, Bongers BC, et al
     Real-life effectiveness of prehabilitation to improve postoperative outcomes in patients with colorectal cancer approaching surgery: A systematic review and meta-analyses of observational studies versus randomized controlled trials.
     Eur J Surg Oncol. 2024;50:108708.
     PubMed     Abstract available
     
     
     
148. LIAO CK, Hsu YJ, Chern YJ, Yu YL, et al
     Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers.
     Eur J Surg Oncol. 2024;50:108687.
     PubMed     Abstract available
     
     
     
149. XIA L, Xu X, Zhang C, Cao G, et al
     Low pneumoperitoneum pressure on venous thromboembolism in laparoscopic colorectal cancer surgery: A randomized controlled study.
     Eur J Surg Oncol. 2024;50:108672.
     PubMed     Abstract available
     
     
     
150. HANSEN SB, Fonnes S, Oggesen BT, Rosenberg J, et al
     High prevalence of erectile dysfunction within the first year after surgery for rectal cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108662.
     PubMed     Abstract available
     
     
     
151. KAWASHIMA J, Chatzipanagiotou OP, Tsilimigras DI, Khan MMM, et al
     Preoperative and postoperative predictive models of early recurrence for colorectal liver metastases following chemotherapy and curative-intent one-stage hepatectomy.
     Eur J Surg Oncol. 2024;50:108532.
     PubMed     Abstract available
     
     
     
152. SUN Y, Jiang W, Tang Z, Wang X, et al
     Textbook outcome in low rectal cancer after neoadjuvant chemoradiotherapy: Post hoc analysis of the LASRE randomized clinical trial.
     Eur J Surg Oncol. 2024;50:108519.
     PubMed     Abstract available
     
     
     
153. FRUHLING P, Stillstrom D, Holmquist F, Nilsson A, et al
     Change in tissue resistance after irreversible electroporation in liver tumors as an indicator of treatment success - A multi-center analysis with long term follow-up.
     Eur J Surg Oncol. 2024;50:108508.
     PubMed     Abstract available
     
     
     
154. RAUWERDINK P, van de Vlasakker VCJ, Wassenaar ECE, Rovers KP, et al
     First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
     Eur J Surg Oncol. 2024;50:108487.
     PubMed     Abstract available
     
     
     
155. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
     PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
     Eur J Surg Oncol. 2024;50:108468.
     PubMed     Abstract available
     
     
     August 2024
156. TRINIDAD-GUTIERREZ I, Vazquez-Borrego MC, Aguilera-Fernandez E, Velez-Castano JE, et al
     Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I.
     Eur J Surg Oncol. 2024;50:108642.
     PubMed     Abstract available
     
     
     
157. RIJSEMUS CJV, Kok NFM, Aalbers AGJ, Fijneman RJA, et al
     Staging peritoneal metastases in colorectal cancer: The correlation between MRI, surgical and histopathological peritoneal cancer index.
     Eur J Surg Oncol. 2024;50:108611.
     PubMed     Abstract available
     
     
     
158. KEARNS EC, Moynihan A, Dalli J, Khan MF, et al
     Clinical validation of 3D virtual modelling for laparoscopic complete mesocolic excision with central vascular ligation for proximal colon cancer.
     Eur J Surg Oncol. 2024;50:108597.
     PubMed     Abstract available
     
     
     
159. YANG X, Zhang Z, Bi X
     A nomogram for predicting colorectal cancer liver metastasis using circulating tumor cells from the first drainage vein.
     Eur J Surg Oncol. 2024;50:108579.
     PubMed     Abstract available
     
     
     July 2024
160. AHMED M, Nabi R, Nadeem M
     Enhancing patient-centered care and addressing psychosocial needs in colorectal cancer: The role of the ABCRC tool.
     Eur J Surg Oncol. 2024 Jul 26:108551. doi: 10.1016/j.ejso.2024.108551.
     PubMed    
     
     
     
161. THOMASSEN BJM, Kimman ML, Somers AMJ, Ponds RWHM, et al
     Reply to: 'Enhancing patient-centered care and addressing psychosocial needs in colorectal cancer: The role of the ABCRC tool'.
     Eur J Surg Oncol. 2024 Jul 20:108552. doi: 10.1016/j.ejso.2024.108552.
     PubMed    
     
     
     
162. BAIK H, Kim J, Seo SH, Kim KH, et al
     Shorter interval to surgery after self-expanding metallic stent may result in better oncologic outcomes in colon cancer obstruction.
     Eur J Surg Oncol. 2024;50:108539.
     PubMed     Abstract available
     
     
     
163. WANG X
     Critical appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological considerations.
     Eur J Surg Oncol. 2024 Jul 3:108521. doi: 10.1016/j.ejso.2024.108521.
     PubMed    
     
     
     
164. SU Y, Li Y, Zhang H, Yang W, et al
     Machine learning model for prediction of permanent stoma after anterior resection of rectal cancer: A multicenter study.
     Eur J Surg Oncol. 2024;50:108386.
     PubMed     Abstract available
     
     
     June 2024
165. MAKI H, Vauthey JN, You YN
     Reply to: Critical Appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological Considerations.
     Eur J Surg Oncol. 2024 Jun 29:108520. doi: 10.1016/j.ejso.2024.108520.
     PubMed    
     
     
     
166. AWAIS AR, Manzoor I, Mansoor M
     Harnessing machine learning to predict colorectal cancer metastasis: A promising artificial intelligence frontier.
     Eur J Surg Oncol. 2024 Jun 26:108493. doi: 10.1016/j.ejso.2024.108493.
     PubMed    
     
     
     
167. JAMES AL, Lattimore CM, Cramer CL, Mubang ET, et al
     The impact of geriatric-specific variables on long-term outcomes in patients with hepatopancreatobiliary and colorectal cancer selected for resection.
     Eur J Surg Oncol. 2024;50:108509.
     PubMed     Abstract available
     
     
     
168. GUO Z, Zhang Z
     Reply to "Harnessing machine learning to predict colorectal cancer metastasis: A promising artificial intelligence frontier".
     Eur J Surg Oncol. 2024 Jun 18:108492. doi: 10.1016/j.ejso.2024.108492.
     PubMed    
     
     
     
169. GAO Z, Qi X, Wang R, Wen Z, et al
     Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108474.
     PubMed     Abstract available
     
     
     
170. KIM S, Huh JW, Lee WY, Yun SH, et al
     Predicting survival in locally advanced rectal cancer with effective chemoradiotherapy response.
     Eur J Surg Oncol. 2024;50:108361.
     PubMed     Abstract available
     
     
     
171. MARJASUO ST, Lehtimaki TE, Koskenvuo LE, Lepisto AH, et al
     Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
     Eur J Surg Oncol. 2024;50:108337.
     PubMed     Abstract available
     
     
     
172. CRIPPA J, Magistro C, Montroni I, Borroni G, et al
     Charting connections: A systematic review of colorectal surgery research networks.
     Eur J Surg Oncol. 2024;50:108322.
     PubMed     Abstract available
     
     
     
173. ZHOU L, Zhang Z, Wang L
     Treatment of anterior resection syndrome: A systematic review and network meta-analysis.
     Eur J Surg Oncol. 2024;50:108336.
     PubMed     Abstract available
     
     
     
174. HOOGTEIJLING TJ, Abu Hilal M, Zimmitti G, Aghayan DL, et al
     Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.
     Eur J Surg Oncol. 2024;50:108309.
     PubMed     Abstract available
     
     
     
175. PETRELLI F, Arru M, Colombo S, Cavallone M, et al
     BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108306.
     PubMed     Abstract available
     
     
     
176. DIETZ MV, Hannink G, Said I, van der Zant FA, et al
     Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
     Eur J Surg Oncol. 2024;50:108294.
     PubMed     Abstract available
     
     
     
177. KHAN JS, Piozzi GN, Rouanet P, Saklani A, et al
     Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
     Eur J Surg Oncol. 2024;50:108308.
     PubMed     Abstract available
     
     
     
178. GEFFEN EGMV, Nederend J, Sluckin TC, Hazen SJA, et al
     Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment.
     Eur J Surg Oncol. 2024;50:108307.
     PubMed     Abstract available
     
     
     
179. VAN HAM NCM, Glazemakers S, van der Ende-van Loon M, Nieuwenhuijzen GAP, et al
     Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
     Eur J Surg Oncol. 2024;50:108259.
     PubMed     Abstract available
     
     
     
180. DE GRAAFF MR, Klaase JM, Dulk MD, Buis CI, et al
     Outcomes of liver surgery: A decade of mandatory nationwide auditing in the Netherlands.
     Eur J Surg Oncol. 2024;50:108264.
     PubMed     Abstract available
     
     
     
181. TEN CATE DWG, Molenaar CJL, Garcia RS, Bojesen RD, et al
     Multimodal prehabilitation in elective oncological colorectal surgery enhances postoperative functional recovery: A secondary analysis of the PREHAB randomized clinical trial.
     Eur J Surg Oncol. 2024;50:108270.
     PubMed     Abstract available
     
     
     May 2024
182. AZLAN A, Rafaqat Z, Ahmad A
     Improving machine learning predictions for metastases in colorectal cancer.
     Eur J Surg Oncol. 2024 May 25:108440. doi: 10.1016/j.ejso.2024.108440.
     PubMed    
     
     
     
183. GUO Z, Zhang Z
     Reply to "Improving machine learning predictions for metastases in colorectal cancer".
     Eur J Surg Oncol. 2024 May 24:108441. doi: 10.1016/j.ejso.2024.108441.
     PubMed    
     
     
     
184. CERESOLI M, Pedrazzani C, Pellegrino L, Ficari F, et al
     Early non compliance to enhanced recovery pathway might be an alert for underlying complications following colon surgery.
     Eur J Surg Oncol. 2024;50:106650.
     PubMed     Abstract available
     
     
     April 2024
185. GUO Z, Zhang Z, Liu L, Zhao Y, et al
     Machine learning for predicting liver and/or lung metastasis in colorectal cancer: A retrospective study based on the SEER database.
     Eur J Surg Oncol. 2024;50:108362.
     PubMed     Abstract available
     
     
     
186. ZHOU X, Lu Y, Wu Y, Yu Y, et al
     Construction and validation of a deep learning prognostic model based on digital pathology images of stage III colorectal cancer.
     Eur J Surg Oncol. 2024;50:108369.
     PubMed     Abstract available
     
     
     
187. ZHENG Y, Wang J, Sun L
     Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis.
     Eur J Surg Oncol. 2024 Apr 23:108344. doi: 10.1016/j.ejso.2024.108344.
     PubMed    
     
     
     
188. KATAOKA K, Ouchi A, Suwa Y, Hirano H, et al
     Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A).
     Eur J Surg Oncol. 2024;50:108354.
     PubMed     Abstract available
     
     
     
189. SAQIB HWU, Abdullah A, Majid A
     "Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis".
     Eur J Surg Oncol. 2024 Apr 16:108345. doi: 10.1016/j.ejso.2024.108345.
     PubMed    
     
     
     
190. CUIJPERS ACM, Lubbers T, Dronkers JJ, Heldens AFJM, et al
     Development and external validation of preoperative clinical prediction models for postoperative outcomes including preoperative aerobic fitness in patients approaching elective colorectal cancer surgery.
     Eur J Surg Oncol. 2024;50:108338.
     PubMed     Abstract available
     
     
     
191. QIAN C, Yang W, Li M, Feng Y, et al
     Negative prognostic impact of Co-mutations in TGFbeta and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
     Eur J Surg Oncol. 2024;50:108242.
     PubMed     Abstract available
     
     
     
192. KNITTER S, Raschzok N, Hillebrandt KH, Benzing C, et al
     Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry.
     Eur J Surg Oncol. 2024;50:108010.
     PubMed     Abstract available
     
     
     
193. CAI Y, Chen M, Ye F, Liu Z, et al
     The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
     Eur J Surg Oncol. 2024;50:108001.
     PubMed     Abstract available
     
     
     March 2024
194. MALIK HZ, Siriwardena AK
     Towards standardized terminology for patients with synchronous colorectal cancer and liver metastases.
     Eur J Surg Oncol. 2024;50:108315.
     PubMed    
     
     
     
195. NUIJENS BW, Lindeboom R, van den Broek JJ, Geenen RWF, et al
     A prediction model for lung metastases in patients with indeterminate pulmonary nodules in newly diagnosed colorectal cancer.
     Eur J Surg Oncol. 2024;50:108305.
     PubMed     Abstract available
     
     
     
196. LENNON D, Ryan OK, Ryan EJ, Martin ST, et al
     "Reply to: An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies".
     Eur J Surg Oncol. 2024 Mar 11:108256. doi: 10.1016/j.ejso.2024.108256.
     PubMed    
     
     
     
197. WANG X
     An insight into the distribution patterns of metastatic lymph nodes in non-metastatic splenic flexure colon cancer: Rationale for surgical management strategies.
     Eur J Surg Oncol. 2024 Mar 7:108255. doi: 10.1016/j.ejso.2024.108255.
     PubMed    
     
     
     
198. VAN DER HULST HC, van der Bol JM, Bastiaannet E, Portielje JEA, et al
     The effect of prehabilitation on long-term survival and hospital admissions in older patients undergoing elective colorectal cancer surgery.
     Eur J Surg Oncol. 2024;50:108244.
     PubMed     Abstract available
     
     
     
199. VOIGT KR, de Graaff MR, Verhoef C, Kazemier G, et al
     Association of modified textbook outcome and overall survival after surgery for colorectal liver metastases: A nationwide analysis.
     Eur J Surg Oncol. 2024;50:107972.
     PubMed     Abstract available
     
     
     February 2024
200. THOMASSEN BJM, Kimman ML, Somers AMJ, Ponds RWHM, et al
     The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study.
     Eur J Surg Oncol. 2024;50:108032.
     PubMed     Abstract available
     
     
     
201. MAKI H, Haddad A, Lendoire M, Newhook TE, et al
     Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases.
     Eur J Surg Oncol. 2024;50:108057.
     PubMed     Abstract available
     
     
     
202. BOLDRIN V, Khaled C, El Asmar A, Kamden L, et al
     Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis.
     Eur J Surg Oncol. 2024;50:107251.
     PubMed     Abstract available
     
     
     March 2023
203. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
     External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
     Eur J Surg Oncol. 2023;49:604-610.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum